BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Genetown

  ASCO15: Foundation Medicine, Inc. Identifies Patients Likely To Respond To Certain MET Inhibitor Targeted Therapies; Durable Responses In Non-Small Cell Lung Cancer (NSCLC) Presented At ASCO Annual Meeting

  June 2, 2015

   · 

  6 min read
• Global Kinetics Corporation Closes $14.8 million Capital Raising

  June 2, 2015

   · 

  3 min read
• FDA

  Cyberonics Announces FDA Approval Of The AspireSR Generator For VNS Therapy

  June 2, 2015

   · 

  6 min read
• Deals

  Prenatal Test Provider Natera Files for $100 Million IPO

  June 2, 2015

   · 

  1 min read
• BioForest

  Breaking: Juno Therapeutics Leaps 15% as AstraZeneca PLC CEO Says It May Be in the CAR-T Market

  June 2, 2015

   · 

  4 min read
• Business

  JenaValve Taps Boston Scientific Exec for CEO Post

  June 2, 2015

   · 

  4 min read
• Deals

  Fitbit Eyes Up to $478 Million in IPO of Wearable Health Device

  June 2, 2015

   · 

  1 min read
• Drug Development

  Merrimack Announces Data From An Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile For MM-398 In High-Grade Glioma

  June 2, 2015

   · 

  6 min read
• FDA

  The European Commission (EC) Approves Helsinn’s Akynzeo (netupitant/palonosetron) for the Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In The European Union

  June 2, 2015

   · 

  7 min read
• Global Kinetics Bags AUD$14.8 Million

  June 2, 2015

   · 

  3 min read